Senators John Cornyn, a Texas Republican, and Richard Blumenthal, a Connecticut Democrat, proposed legislation this week to stop drug companies’ abusive patent tactics that block competition and crush taxpayers and patients.
In the first three months of 2019, PhRMA spent $10 million for 27 in-house lobbyists and 20 outside lobbyists. Swampy.
Welcome to the week in drug pricing news — no redactions.
New data from the Centers For Medicare & Medicaid Services emphasized the need for Congress to pass the CREATES Act, a bipartisan bill that would lower drug prices and save taxpayers billions.